Do you have a history of coronary artery disease?
Have you had stents or bypass surgery?
Our cardiac stem cell therapy clinic is led by Dr. Howard Walpole, a prominent U.S. cardiologist with 25 years of practice.
Okyanos Heart Institute is the first healthcare provider to offer cardiac stem cell therapy in a state-of-the-art clinical setting.
The mission of Okyanos Heart Institute is to bring a new standard of care and a better quality of life to patients with coronary artery disease using cardiac stem cell therapy.
Adult stem cell therapy treatment for coronary artery disease advanced to a higher level with the announcement of the PRECISE clinical trial results at the annual meeting of the American Heart Association (AHA) in November, 2010. Using stem cells harvested from a patient’s own body fat, the rigorous clinical trial demonstrated patient improvement in cardiac function and reduction of infarct (wound) size.
The cells used in the PRECISE trial are technically known as adipose (fat)- derived stem and regenerative cells (ADRCs), and have been shown to encourage the growth of new blood vessels when placed directly into the heart muscle. Those vessels are believed to support better heart function and prevent further scarring of the heart. Improved heart function can in turn translate to a better quality of life for the patient.
Okyanos Treatment is based on a sound scientific safety record in a double-blind, placebo-controlled clinical trial, but is not commonly applied yet as a standard of care. Patients’ heart function outcomes, including changes in quality of life of all patients who are treated with Okyanos Treatment, will be documented in a patient registry. The Okyanos medical team will confer with the primary physician or cardiologist once the patient returns home to monitor progress on a regular basis. By doing so, efficacy can be evaluated and modes of therapy can be adjusted. Insurance does not yet cover stem cell treatments.
Located in Freeport, Bahamas, the Institute is built to U.S., European and Bahamian surgical center standards, and is led by Dr. Howard Walpole, a prominent U.S.-educated interventional cardiologist. At Okyanos, the focus is on offering a highly personalized patient and family experience to facilitate maximum treatment, recovery and benefit.
The Institute expects to begin treating patients in late Spring of 2014.